| (Values in U.S. Thousands) | Dec, 2022 | Dec, 2021 | Dec, 2020 | Jun, 2026 | Jun, 2026 |
| Sales | 630 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -18,000 | 4,690 | -200 | 0 | 0 |
| Net Income Growth | -483.80% | +2,445.00% | unch | unch | unch |
Comera Life Sciences Holdings Inc (CMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Comera Life Sciences Inc. is involved in developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience. Comera Life Sciences Inc., formerly known as OTR Acquisition Corp., is based in WOBURN, Mass.
Fiscal Year End Date: 12/31